Panasonic Introduces the Shoe Deodorizer: Deodorizes Your Shoes While You Sleep
Panasonic Corporation will begin selling a shoe deodorizer, the MS-DS100, equipped with "nanoe X" that generates 10 times(*2) more hydroxyl (OH) radicals than "nanoe" to remove unpleasant shoe odors in a simple way, on September 20, 2018 (in Japan only).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180810005082/en/
Panasonic shoe deodorizer MS-DS100 (Photo: Business Wire)
One of the common causes of unpleasant shoe odors is isovaleric acid, an odorous substance produced by foot sweat and bacteria. According to a survey(*3) Panasonic conducted with sneaker wearers, about 62% of those surveyed take some measures to remove shoe odors, but about half of them are not satisfied with the deodorizing methods they use.
The MS-DS100 utilizes Panasonic's original ion particles, "nanoe
X," to dissolve and eliminate unpleasant shoe odors(*1). When the
product is set in shoes and the switch turned on, "nanoe X" is generated
and spreads from six outlets to every corner of the shoes to remove
odors(*1) in the entire interior of the shoes from the heel to the toe.
There are two operation modes to choose from. The normal mode provides approximately five hours of operation, while the long mode runs for about seven hours to remove stubborn odors. Both modes cost less than 1 yen(*4) per use, so it is very economical. The MS-DS100 also operates on a mobile battery(*5) so it can be used at a place where there is no AC power outlet. The product comes with a stylish storage case. The case accommodates the cap sections that are inserted into shoes for use, so the product can be stored neatly in the entrance area or shoe cupboard.
With the MS-DS100 shoe deodorizer, Panasonic proposes an easy way to remove shoe odors and expects to create new market demand.
|Product name: Shoe Deodorizer|
|Product No.: MS-DS100|
|Suggested retail price: Open price|
|Launch date: September 20, 2018|
|Monthly production volume: 1,000 units|
|1.||Uses "nanoe X" to dissolve and eliminate shoe odors(*1)|
|2.||Economical operation with electricity cost of less than 1 yen(*4) per use. Also operates on a mobile battery(*5).|
|3.||Storage case provided with the product features a stylish design to look attractive when placed in an entrance area.|
For more details, please visit https://news.panasonic.com/global/topics/2018/60160.html
*1: Effect of deodorizing foot odors (isovaleric acid) adhered to shoes. Testing laboratory: Panasonic Corporation, Product Analysis Center. Testing method: 6-stage odor intensity measurement method in an about 10-m2 test room. Deodorizing method: Generation of "nanoe." Test result: Odor intensity decreased by 1.5 in 5 hours. Test result certificate issuing date: June 4, 2018. Test result certificate number: 1V332-180604-K01.
- Test results were not obtained under actual use conditions.
- Deodorizing effect varies depending on the ambient conditions (temperature, humidity), operating time, type of odor, and type of textile.
- Sensitivity to the deodorizing effect may vary from individual to individual.
*2: According to the results of Panasonic's measurement conducted based on the ESR method. Comparison between 480 billion "nanoe" particles/second and 4,800 billion "nanoe X" particles/second.
*3: According to the results of Panasonic's Internet survey conducted in June 2018 with males and females (N = 2,000) in their 10s to 60s
*4: Calculated based on the new electricity rate of 1 kWh = 27 yen (including tax)
*5: For normal mode, use a mobile battery with a capacity of 3,760 mAh
or more (rated output: 5.0 VDC, 1.8 A). For long mode, use a mobile
battery with a capacity of 5,000 mAh or more (rated output: 5.0 VDC, 1.8
A). Operation on a mobile battery cannot be guaranteed since the
operating time may differ depending on the usage conditions, environment
and other factors.
- Mobile battery is not supplied with the product.
"nanoe" technology site
Panasonic Introduces the Deodorizing Hanger - A New Way to Care for Your
Clothes Simply by Placing Them on a Hanger (Jul 03, 2017)
Panasonic Develops a High Performance Nano-sized Electrostatic Atomized
Water Particle "nanoe X" Device, Which Inhibits Pollen, Allergens, and
Odor (Nov 01, 2016)
Global Communications Department
Global PR Office
Click here to go to Media Contact form
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Hilton Launches New Brand, Signia Hilton, Delivering Sophisticated Travel While Reimagining Meetings and Events22.2.2019 17:00:00 | Pressemelding
Hilton (NYSE: HLT) today announced the launch of Signia Hilton, its dynamic, new meetings-and-events-focused brand. The portfolio of hotels is setting out to transform the industry for meeting professionals and sophisticated business travelers by infusing state-of-the-art technology and design into every aspect of the guest experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005071/en/ The brand further reinforces Hilton’s commitment to innovation that meets the evolving needs of today’s travelers and will bring premium experiences to top urban and resort destinations around the world. “In our 100th year of hospitality, we are more focused than ever on providing exceptional experiences to all of our guests – and that includes evolving those experiences to meet their changing needs,” said Christopher J. Nassetta, president and CEO, Hilton. “We are proud to launch Signia Hilton, which exemplifies our innovative sp
Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans22.2.2019 16:30:00 | Pressemelding
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today that it has received CE mark approval for 1.5T and 3T full-body magnetic resonance imaging (“MRI”) conditional labeling for the Axonics r-SNM® System. The Axonics r-SNM System is the only implantable SNM system that has received full-body MRI conditional labeling for sale in Europe1. Raymond W. Cohen, Chief Executive Officer of Axonics, said, “Without this labeling, any patient requiring an MRI scan on any body part below the head must have their neurostimulator surgically explanted prior to the MRI scan, resulting in an additional surgery for the patient and additional costs to patients and the healthcare system. This authorization of full-body MRI scans in Europe is another important milestone for Axonics, differentiating our te
Fantastec Joins Forces with Arsenal FC Launching Official Blockchain Collectibles App22.2.2019 14:30:00 | Pressemelding
Fantastec announced today its first football licensing agreement with Premier League club Arsenal FC for a new blockchain authenticated collectibles app called Fantastec SWAP. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005277/en/ Arsenal players appear on Fantastec SWAP in official licensing deal (Graphic: Business Wire) London-based Fantastec is a leading sports fan technology innovator, and its blockchain based ‘SWAP’ app will have broad appeal to global sports fans, gamers and sports card collectors alike. Fantastec SWAP unlocks unique and authentic club content through the app, like player autographs and exclusive footage. With its innovative blockchain technology, fans around the world can now discover, collect and swap officially licensed club collectibles with other fans with complete trust. “Fantastec SWAP is a game-changer for international football fans as well the sports collectibles industry,” commented
Volkswagen Protects Virtual Key Sharing App with Trustonic Application Protection22.2.2019 13:42:00 | Pressemelding
Volkswagen is working with mobile cyber security leader Trustonic to enable customers to use smartphones to access their vehicles, and to securely share their digital car keys to grant access to others via a smartphone app. Volkswagen is using the Trustonic Application Protection (TAP) platform to secure the mobile app and ensure that sensitive information and key transfer requests are securely displayed to, and approved by, a real authenticated user on a trusted device and not by hackers or malware simulating a user or device. “The smartphone is becoming the vehicle key of the future and our We Connect service is the interface for this today in the new Volkswagen Passat,” comments Alf Pollex, Head of Infotainment and Connected Car at Volkswagen AG. “The user installs the We Connect app on their smartphone which is then authorized via the infotainment system with a Transaction Number. The Mobile Key will be compatible with Android-based Samsung devices. No mobile network connection is
Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer22.2.2019 13:30:00 | Pressemelding
Mundipharma EDO GmbH, part of the Mundipharma network of independent associated companies, and Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., today announced that the US FDA has granted Orphan Drug Designation (ODD) to etoposide toniribate for the treatment of relapsed/refractory biliary tract cancer, also known as cholangiocarcinoma.3 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190222005126/en/ Biliary tract cancer is a rare tumour with approximately 8,000 patients diagnosed in the US every year and 10,571 in Europe.4,5 The FDA grants ODD status to medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US. Radical surgery is the only curative treatment for biliary tract cancer but, in most cases, the cancer is inoperable. Patients who fail first-line chemotherapy have limited treatment options and the standard of
Lenovo Data Center Group Delivers Broad Edge Computing Portfolio, Expands Investments in IoT22.2.2019 13:13:00 | Pressemelding
Next week at MWC Barcelona, Lenovo Data Center Group (DCG) will showcase continued investments in its solutions supporting IoT and edge computing as part of its IoT growth plan over the next few years. Building on the momentum of its fifth consecutive quarter of profit growth, Lenovo DCG is building a portfolio that takes infrastructure to where the data is, whether that be in the traditional data center, in the cloud or increasingly, at the edge. Today, around 10 percent of enterprise-generated data is created and processed outside a traditional centralized data center or cloud. By 2022, Gartner predicts this figure will reach 75 percent. This migration is driving increased concerns around data privacy, security and regulations coupled with challenges of latency, bandwidth and downtime. Lenovo is addressing these challenges by creating a broad portfolio of edge computing offerings that address the different ways that customers want to deploy edge computing solutions for IoT use cases.